Lazard Asset Management LLC Adma Biologics, Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 251,910 shares of ADMA stock, worth $4.69 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
251,910
Previous 203,108
24.03%
Holding current value
$4.69 Million
Previous $2.27 Million
121.81%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ADMA
# of Institutions
320Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$347 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$338 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$242 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$235 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$160 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.66B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...